https://wholefoodsmagazine.com/columns/debates/kratom-for-chronic-pain/#
Kratom is not legally marketed in the U.S. as a drug or dietary supplement, according to the FDA. But people still use it. Fibromyalgia experts discuss Kratom as a pain relief option used under a healthcare provider’s guidance.
Lower Risk than Opiods
by Jacob Teitelbaum, M.D.
With one third of Americans suffering with chronic pain, approximately 50,000 preventable U.S. deaths each year from arthritis medications (e.g. NSAIDs like ibuprofen), and 5,000 yearly deaths from prescribed narcotics used as directed, we clearly have a major problem in how we treat chronic pain.
Having effectively treated thousands of people with fibromyalgia and other forms of severe chronic pain, and published a number of studies and textbook chapters on this, one simple fact has become very clear: Virtually all pain can be effectively treated, by using the entire healthcare toolkit. This includes both natural and prescription options, as well as socially controversial natural treatments such as marijuana, hemp oil, and kratom.
For example, numerous studies show that using natural options such as a special mix called Curamin, and even a mix of glucosamine plus chondroitin, is as or more effective than arthritis medications. And could save over 50,000 lives a year.
If not for a deadly quirk in our government’s regulatory system.
Basically, it costs anywhere from $100 million to $2.6 billion to put a single treatment through the FDA regulatory system. As nobody can pay this for non-patentable treatments, the enormous body of research using safe natural and low-cost generic medications cannot be effectively discussed or publicized.
Including Kratom.
Natural remedies, and Kratom is no exception, are not without risk. They simply carry much lower risks than medications. Although in my experience it has been uncommon if the dose is properly regulated, some people will develop cravings or even tolerance to this herbal. So I do not begin with this. Still, I have seen people who failed dozens of other herbals and medications, including narcotics, and had dramatic relief with Kratom.
As a physician, one learns to do a risk/benefit analysis. This includes looking at the validity of the data being used. As of 2017, the FDA reported 44 deaths worldwide associated with Kratom. But it is important to understand what the words “associated with” mean: simply that if they found any evidence of Kratom in the bloodstream when somebody died, even if they had a massive narcotic overdose and a gallon of tequila in them, this death is then “associated with” Kratom (1).
This faulty approach would claim that millions of deaths are associated with the use of milk, coffee or even toilet paper.
The bottom line? Kratom can be a very helpful tool in the healthcare toolkit when used with a health practitioner’s guidance; Kratom is far safer than ibuprofen and codeine; and Kratom should be reserved for when other natural treatment options have failed. To make it illegal will trigger far more suffering and deaths than it would prevent.
Still Too Risky
by Ginevra Liptan, M.D.
Kratom has significant medicinal potential for both pain management and easing opioid withdrawal, but most health care professionals do not recommend it due to safety concerns. Regardless of medical advice, consumers are using it—over 2 million Americans take kratom every year. While kratom is currently sold over the counter, its legal status is murky. Sales of kratom have been banned in six U.S. states, and in 2016 the DEA attempted to make it a Schedule I drug, but backed off after a public outcry.
I’ve found a surprising number of my patients are trying kratom without informing any of their doctors. Several of my patients report significant pain reduction with kratom, with some using it to successfully wean themselves off prescription opioids. Health care providers need to understand the pharmacology of this plant so they can discuss the risks and benefits with their patients.
Kratom has well documented medicinal actions, but its pharmacology is complex. The effects of kratom on the body are dosage dependent, lower doses give stimulant effects and larger doses provide analgesic and sedative effects. Kratom contains at least 40 different known phytochemicals with actions on multiple brain receptors. Its main active ingredients bind primarily to opioid receptors.
The biggest benefit of kratom is that while it has analgesic effects comparable to morphine, it causes less constipation, respiratory depression, and tolerance compared to opioids. However chronic use is not without risk and has been associated with drug dependency and development of opioid withdrawal symptoms. Rare side effects of kratom include psychosis, hypertension and liver failure. Although kratom has less respiratory suppression effects compared to opioids, it still can be deadly when mixed with other compounds. There are case reports of overdose deaths due to mixtures of kratom with over-the-counter cold medications, sleep medications, or benzodiazepines. However in total, kratom appears to be a much safer option than opioids.
Currently the biggest safety issue around kratom is the lack of supplement consistency and quality control as it is not being produced by any large or reputable supplement companies. There have been concerning reports of products adulterated with medications, or contaminated by bacteria, as occurred in a multistate Salmonella outbreak.
Kratom does have exciting therapeutic potential as a pain treatment, but for it to be really useful medically we need more information about safe dosing and interactions with other medications and access to high quality, standardized products.
A picture is worth a thousand words.
This one shows that the analgesia on the receptor sites of the lab mouse's brain are not activated by Mitragynine directly, but by liver's CYP3A enzymatically mediated conversion of Mitragynine into 7-HydroxyMitragynine, an active metabolite that is 50 times more potent.
Now for those 1000 words that I spoke of: Grab a cup of the favorite tea of your choice 
...and cuddle up with your lab mouse to this amazingly enlightening, yet so unnessesarily complex article right here:
https://www.ncbi.nlm.nih.gov/p...
Don't fret if it became too confusing with all of the sciencey mumbo~jumbo. Just skip over the terminological inexactitudes and indeterminate specificities, 'cuz there be more gooder stuff 'tween them thar maths.
Short abstract:
Mitragynine is the major active alkaloid of Mitragyna speciosa (kratom). This compound is converted by the liver into a potent active metabolite, 7-hydroxyMitragynine, which mediates its analgesic effect via the mu-opioid receptor. 
🤯
~~<Translation so that Petey's ever shrinking brain can comprehend>~~
Natural kratom leaf, by weight, has 1~2% moderately potent Mitragynine, and a tiny fraction of 1% of VERY potent 7-HydroxyMitragynine (or 7-OHM for short). The natural level of VERY potent 7-OHM, that exists in the leaf, is insufficient to cause the observed levels of analgesia (pain relief) that were encountered.
In the leaf, Mitragynine is more abundant but not very powerful, however the research theorizes that enzyme CYP3A metabolizes the weaker Mitragynine into potent 7-OHM, after it's first pass through the liver. This increases the available levels of potent 7-OHM and explains the high level of analgesia (pain relief) observed in the lab mouse. 
Perhaps growers and enthusiasts alike should be more concerned with good levels of Mitragynine that naturally occur, and let our liver do the hard work of synthesizing 7-OHM. 
Now aren't you glad that you read the article instead.
Cheers! 
(not sorry for the emoticons) 
ps. I wish I was a lab mouse. 
Here is a clone with cinnamon around its tender stem. There is white mold trying to encroach but it is stopped at the cinnamon's edge...
and a closer view of the mold...
Cinnamon does work to protect young cuttings until they have a thicker resistant bark.
I attached an article about hopeful UF medicinal testing and research on Kratom.
I hope that this guy, Christopher McCurdy, a professor of medical chemistry for the University of Florida College of Pharmacy, doesn't turn out to be another 'Pfizer-owned' Scott Gottlieb FDA clown type, but rather is a valuable ally for Kratom's continued use and legal status.
Notably, McCurdy is recognized as one of the foremost International experts on Mitragyna speciosa. For more than a decade, McCurdy has collaborated with Edward W. Boyer, M.D., Ph.D. (Harvard/Brigham and Women’s Hospital), Bonnie A. Avery, Ph.D., Stephen J. Cutler, Ph.D. (Dean, University of South Carolina College of Pharmacy), and Scott E. Hemby, Ph.D. (High Point University School of Pharmacy) on investigations into the therapeutic potential for kratom.
Article is here:
https://www.westword.com/news/...
Enjoy....
I support the
The only plants I'm not having any problems with right now are my junior bumblebee kratom.
Since we have more new people here I'll post this question again. Not having any prior experience with this strain is the Bumblebee Kratom worth my time and energy. I ask because I don't see specific bumblebee Kratom powder for sale
HO, Ho, Ho Marry Christmas. Our team at Kratomleaf.us thought we would bring a bit of merry to this holiday season by starting our Christmas Kratom Sale! For the 12 days before Christmas (12/13/19 - 12/25/19) all Fertile American Kratom Seed Pods and Fresh Raw Organic American Kratom Leaf will be 25% OFF. Use Promo Code "Merry Christmas" at checkout to receive this special offer.
Click here to Complete YOUR Holiday Wish list Today!!
Kratom FAQ
This Kratom FAQ has been compiled to help people gain a better understanding of Kratom and how it can work in the body and also help debunk false myths about Kratom. Some of the Questions and subsequent answers are quite technical, so we have attempted to define some of the more important keywords for you. If you get confused, feel free to shoot us an email with further questions.
KRATOM TREES (MITRAGYNA SPECIOSA) TREES USUALLY GROW TO A HEIGHT OF 12–30 FT (3.7–9.1 M) TALL AND 15 FT (4.6 M) WIDE, ALTHOUGH SOME SPECIES CAN REACH 40–100 FT (12–30 M) IN HEIGHT.
Q: What is Kratom?
A: Kratom is a tree native to Southeast Asia in the Indochina and Malaysia floristic regions. Its botanical name is Mitragyna Speciosa [mih-tr-ah-jin-yah | spee-see-OH-sah]. Kratom is in the same family as the coffee tree Rubiaceae. The leaves of Kratom have been used as an herbal drug for centuries by peoples of Southeast Asia.
Q: What are the effects of Kratom?
A: At lower doses, it is used in folk medicine as a stimulant, reducing stress, anxiety and depression*, and at higher doses acts as a sedative for painkiller, recreational and medicinal use. Finally, Kratom is reported as being used for withdrawal treatment for opiate addiction and recovery*. For more details about this topic, please visit our kratom effects.
Q: What’s in Kratom?
A: Chemistry Make up of Kratom:
There are 40 compounds in M. speciosa leaves,[6] including many alkaloids such as mitragynine (once thought to be the primary active constituent), mitraphylline, and 7-hydroxymitragynine (which is currently the most likely candidate for the primary active chemical in the plant).[10][11] Other active chemicals in M. speciosa include raubasine (best known from Rauwolfia serpentina) and some Yohimbe alkaloids such as corynantheidine.[12]
Mitragyna speciosa also contains at least one alkaloid (rhynchophylline) that is a calcium channel blocker and reduces NMDA-induced current.[13][14] There is considerable research as to the role of NMDA receptor activity in the formation of dependence, and the symptoms of withdrawal.
Q: What are Alkaloids?
A: Alkaloids are a group of naturally occurring chemical compounds, that contain mostly basic nitrogen atoms.
Q: I hear the use of the term ANALGESIC. What does that term mean and how is it relevant to Kratom?
A: An analgesic, or painkiller, is any member of the group of drugs used to achieve analgesia — relief from pain. The word analgesic derives from Greek αν – (“without”) and άλγος – (“pain”).[3]
There are many types of analgesic drugs from anesthesia to opiates such as oxycontin, oxycodone, Percocet, and Vicodin. It is relevant to Kratom since Kratom is considered analgesic in nature.
Q: What’s the best way to use Kratom?
A: This is mostly about personal preference. Using kratom capsules provides convenience and a tasteless/odorless experience. Using kratom powder, while more involved, generally produces quicker effects. So, it’s really up to you.
Q: Is Kratom safe?
A: When used in moderation, kratom is safe.
Q: Can you overdose on Kratom?
A: No reports from overdose on kratom alone are documented. Unlike other drugs such as Oxycontin or Vicodin which are synthetic, Kratom is unique due to the fact that if you take a dose stronger than your body needs it will expel it naturally. Taking Kratom by itself has not been found to result in overdose.
Q: Can I get sick from using too much Kratom?
A: Every pro can have a con. Here it is: Yes, it is possible to get minor hot flashes and a tummy ache. This effect will generally last 30-60 minutes. Please keep in mind, this effect only occurs if you have used more than the body needs. If this occurs, drink a cool glass of water and lay down in a dimly lit room.
Q: I have heard about Hypoventilation and it being associated with overdoses. What is Hypoventilation and can this happen with using Kratom?
A: No, Hypoventilation has not been reported to occur when you use Kratom independently, without any other substance. Read more below about hypoventilation.
Hypoventilation: In medicine, hypoventilation (also known as respiratory depression) occurs when ventilation is inadequate (hypo meaning “below”) to perform the needed gas exchange.[1] By definition, it causes an increased concentration of carbon dioxide (hypercapnia) and respiratory acidosis.
Causes: It can be caused by medical conditions, such as stroke affecting the brainstem, by holding one’s breath, or by drugs, typically when taken in overdose. Hypoventilation may also occur in chronic mountain sickness to conserve energy. [2]
Effects: As a side effect of prescription medicines or illicit recreational drugs, hypoventilation may become potentially life-threatening. Many different CNS depressant drugs such as alcohol, benzodiazepines, barbiturates, GHB, sedatives, and opiates produce respiratory depression when taken in large or excessive doses; however, this is most commonly seen as a cause of death with opiates or opioids, particularly when they are combined with sedatives such as alcohol or benzodiazepines. This has NOT however been reported as a possible side effect of using Kratom.
Q: How is Kratom said to work in the brain?
A: As of late 2011, no controlled, clinical studies have been performed on humans. Therefore, its metabolic half-life, protein binding, and elimination characteristics are all unknown within the scientific world.[5] We do know that Kratom behaves as a μ-opioid receptor agonist, similar to opiates like morphine, although its effects differ significantly from those of opiates.[5]Kratom does not appear to have significant adverse effects, and in particular appears NOT to cause the hypoventilation typical of other opioids.[5]
Q: What is a μ- Opioid Receptor (MOR) and why is it important to talk about?
(see reference Section 2 for notations)
A: μ-(pronounced MU) opioid receptors are the receptors in your brain associated with pain. Kratom is said to be an agonist of these receptors; theory suggests it activates the receptors and aids the body to block the reception of pain signals, similar in nature to an opiate but without the negatives. We feel individuals should be knowledgeable about the theories on how kratom interacts with the brain and body in order to be fully cognizant of what is going on when using kratom and to combat the myths about Kratom use. So, read below!
Active and inactive μ-opioid receptors.[1] The μ-opioid receptors (MOR) are a class of opioid receptors with high affinity for enkephalins and beta-endorphin but low affinity for dynorphins. They are also referred to as μ opioid peptide or (MOP) receptors. The prototypical μ receptor agonist is the opium alkaloid morphine; μ (mu) refers to morphine.
SUBQUESTION: Wait a minute, this is complicated….What’s an Agonist?
A: An agonist is a chemical that binds to some receptor of a cell within the body and triggers a response by that cell. Agonists often mimic the action of a naturally occurring substance. So, an agonist causes an action, and an antagonist blocks the action of the agonist and an inverse agonist causes an action opposite to that of the agonist.
TYPES of μ Receptors :
Three variants of the μ opioid receptor are well-characterized, though reverse-transcriptase PCR has identified up to 10 total splice variants in humans (we have complicated brains eh?).[2][3]
- μ1 –More is known about the μ1 opioid receptor than is known about the other types.
- μ2 –TRIMU 5 is a selective agonist of the μ2 receptor.[4]
- μ3 –In 2003, a μ3 variant was described,[5] which was responsive to opiate alkaloids but not opioid peptides.[6]
Q: Where are these receptors located?
A: In layman’s terms, they are within the brain and in the spinal cord.
Here’s the technical science behind them:
They can exist either presynaptically or postsynaptically depending upon cell types.
The μ-receptors exist mostly presynaptically in the periaqueductal gray region, and in the superficial dorsal horn of the spinal cord (specifically the substantia gelatinosa of Rolando). Other areas where μ-receptors have been located include the external plexiform layer of the olfactory bulb, the nucleus accumbens, in several layers of the cerebral cortex and in some of the nuclei of the amygdala, as well as the nucleus of the solitary tract.
μ receptors are also found in the intestinal tract. This causes constipation, a major side effect of μ agonists, due to inhibition of peristaltic action.
Q: Ok, I think I understand a bit more about all of this. Now, what about Activating all of this?
A: MOR can mediate acute changes in neuronal excitability via “disinhibition” of presynaptic release of GABA (see works from “Charles Chavkin, PhD.;”. and “Roger Nicoll, M.D.;”. ). Activation of the MOR leads to different effects on dendritic spines depending upon the agonist and may be an example of functional selectivity at the μ receptor.[7]
Activation of the μ receptor by an agonist causes analgesia, sedation, slightly reduced blood pressure, itching(with certain agonists like morphine), euphoria, decreased respiration (again, no fear of HYPOVENTILATION using Kratom!), miosis (constricted pupils) and decreased bowel motility. Some of these effects, such as analgesia, sedation, euphoria and decreased respiration, tend to lessen with continued use as tolerance develops.
We hope the Kratom FAQ section has helped you learn more about this special herb.
References
- Zhorov BS, Ananthanarayanan VS (March 2000). “Homology models of mu-opioid receptor with organic and inorganic cations at conserved aspartates in the second and third transmembrane domains”. Arch. Biochem. Biophys. 375 (1): 31–49. doi:10.1006/abbi.1999.1529. PMID 10683246.
- Dortch-Carnes J, Russell K (2007). “Morphine-stimulated nitric oxide release in rabbit aqueous humor”. Exp. Eye Res. 84 (1): 185–90. doi:10.1016/j.exer.2006.09.014. PMC 1766947. PMID 17094965.
- Pan L, Xu J, Yu R, Xu MM, Pan YX, Pasternak GW (2005). “Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm”. Neuroscience. 133 (1): 209–20. doi:10.1016/j.neuroscience.2004.12.033. PMID 15893644.
- Eisenberg RM (1994). “TRIMU-5, a μ2-opioid receptor agonist, stimulates the hypothalamo-pituitary-adrenal axis”. Pharmacol. Biochem. Behav. 47 (4): 943–6. doi:10.1016/0091-3057(94)90300-X. PMID 8029266.
- Cadet P, Mantione KJ, Stefano GB (2003). “Molecular identification and functional expression of μ3, a novel alternatively spliced variant of the human μ opiate receptor gene”. J. Immunol. 170 (10): 5118–23. PMID 12734358.
- Stefano GB (2004). “Endogenous morphine: a role in wellness medicine”. Med. Sci. Monit. 10 (6): ED5. PMID 15173675.
- Liao D, Lin H, Law PY, Loh HH (February 2005). “Mu-opioid receptors modulate the stability of dendritic spines”. Proc. Natl. Acad. Sci. U.S.A. 102 (5): 1725–30. Bibcode:2005PNAS..102.1725L. doi:10.1073/pnas.0406797102. JSTOR 3374498. PMC 545084. PMID 15659552.
- Liu X-Y, Liu Z-C, Sun Y-G, Ross M, K S, Tsai F-F, Li Q-F, Jeffry J, Kim J-Y, Loh HH, Chen Z-F. “Unidirectional Cross-Activation of GRPR by MOR1D Uncouples Itch and Analgesia Induced by Opioids”. Cell 147 (2): 447–458. doi:10.1016/j.cell.2011.08.043. PMC 3197217. PMID 22000021. Lay summary – Washington University in St. Louis Press Release.
- Martini L, Whistler JL (October 2007). “The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence”. Current Opinion in Neurobiology 17 (5): 556–64. doi:10.1016/j.conb.2007.10.004. PMID 18068348.
- Zuo Z (September 2005). “The role of opioid receptor internalization and beta-arrestins in the development of opioid tolerance”. Anesthesia and Analgesia 101 (3): 728–34, table of contents. doi:10.1213/01.ANE.0000160588.32007.AD. PMID 16115983.
- Marie N, Aguila B, Allouche S (November 2006). “Tracking the opioid receptors on the way of desensitization”. Cellular Signalling 18 (11): 1815–33. doi:10.1016/j.cellsig.2006.03.015. PMID 16750901.
- DuPen A, Shen D, Ersek M (September 2007). “Mechanisms of opioid-induced tolerance and hyperalgesia”. Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses 8 (3): 113–21. doi:10.1016/j.pmn.2007.02.004. PMID 17723928.
- Garzón J, Rodríguez-Muñoz M, Sánchez-Blázquez P (May 2005). “Morphine alters the selective association between mu-opioid receptors and specific RGS proteins in mouse periaqueductal gray matter”. Neuropharmacology 48 (6): 853–68. doi:10.1016/j.neuropharm.2005.01.004. PMID 15829256.
- Hooks SB, Martemyanov K, Zachariou V (January 2008). “A role of RGS proteins in drug addiction”. Biochemical Pharmacology 75 (1): 76–84. doi:10.1016/j.bcp.2007.07.045. PMID 17880927.
- Sirohi S, Dighe SV, Walker EA, Yoburn BC (November 2008). “The analgesic efficacy of fentanyl: relationship to tolerance and mu-opioid receptor regulation”. Pharmacology, Biochemistry, and Behavior 91 (1): 115–20. doi:10.1016/j.pbb.2008.06.019. PMC 2597555. PMID 18640146.
- Lopez-Gimenez JF, Vilaró MT, Milligan G (November 2008). “Morphine desensitization, internalization, and down-regulation of the mu opioid receptor is facilitated by serotonin 5-hydroxytryptamine2A receptor coactivation”. Molecular Pharmacology 74 (5): 1278–91. doi:10.1124/mol.108.048272. PMID 18703670.
- Kraus J (2009). “Regulation of mu-opioid receptors by cytokines”. Frontiers in Bioscience (Scholar Edition) 1: 164–70. PMID 19482692.
- García-Fuster MJ, Ramos-Miguel A, Rivero G, La Harpe R, Meana JJ, García-Sevilla JA (November 2008). “Regulation of the extrinsic and intrinsic apoptotic pathways in the prefrontal cortex of short- and long-term human opiate abusers”. Neuroscience 157 (1): 105–19. doi:10.1016/j.neuroscience.2008.09.002. PMID 18834930.
- Ueda H, Ueda M (2009). “Mechanisms underlying morphine analgesic tolerance and dependence”. Frontiers in Bioscience 14: 5260–72. doi:10.2741/3596. PMID 19482614.
REFERENCE SECTION 2:
**1. **“hypoventilation” at Dorland’s Medical Dictionary
**2. **Zubieta-Calleja, GR; Paulev, PE; Zubieta-Calleja, L; Zubieta-Calleja, N; Zubieta-Castillo, G (September 2006). “Hypoventilation in chronic mountain sickness: a mechanism to preserve energy.”. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society. 57 Suppl 4: 425–30. PMID 17072073. Cite uses deprecated parameters (help)
**3. **Harper,D. (2001). “Online Etymology Dictionary: Analgesia”. Retrieved December 3, 2012.
5. Ward J, Rosenbaum C, Hernon C, McCurdy CR, Boyer EW (December 2011). “Herbal medicines for the management of opioid addiction: safe and effective alternatives to conventional pharmacotherapy?”. CNS Drugs25 (12): 999–1007. doi:10.2165/11596830-000000000-00000. PMID 22133323. **6. ** Adkins, Jessica E.; Edward W. Boyer, Christopher R. McCurdy (2011-05-01). “Mitragyna speciosa, a psychoactive tree from Southeast Asia with opioid activity.”. Current Topics in Medicinal Chemistry **10. ****^**Chittrakarn, S; Keawpradub, N; Sawangjaroen, K; Kansenalak, S; Janchawee, B (2010). “The neuromuscular blockade produced by pure alkaloid, mitragynine and methanol extract of kratom leaves (Mitragyna speciosa Korth.)”. Journal of Ethnopharmacology 129 (3): 344–349. doi:10.1016/j.jep.2010.03.035. PMID 20371282.
**11. **Prozialeck, WC; Jivan, JK; Andurkar, SV (2012). “Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic, and opioid-like effects”. The Journal of the American Osteopathic Association 112 (12): 792–799. PMID 23212430.
**12. **Takayama H, Ishikawa H, Kurihara M, Kitajima M, Aimi N, Ponglux D et al. (2002). “Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: discovery of opioid agonists structurally different from other opioid ligands”. J Med Chem 45 (9): 1949–1956. doi:10.1021/jm010576e. PMID 11960505.
**13. **Microgram Bulletin – Department of Justice
**14. **Hendrickson, JB, Sims JJ. Mitragyna alkaloids – The structure of stipulatine. Tetrahedron Letters 1963;14:959-963
Does anyone else use this beautiful plant to manage their pain without fear of damaging your liver?
Kratom Keychain by winter waterfall Get your Kratom Keychain Today!
Ever wish you could carry a little bit of kratom wherever you go? Next time your loved ones ask what Kratom is? You can show them the truth, it’s a tree. Grown in the perfect environment in the United States to display in a Encased kratom keychains you cant take with you on your personal life’s journey. Each individual Encased kratom keychains Heart Leaf are completely unique. Our leaves are preserved and sealed for longevity as well as quality. They make great gifts for your family and friends. Enjoy the holidays with a special gift you will never forget.
We select our finest leaf specimens from our kratom trees grown in the United States to display in a Kratom Keychains you cant take with you on your life’s journey. Each individual kratom keychains are completely unique because every leaf is unique. The Kratom leaf in the encased Kratom keychain holds it’s form for up to a year. Some have even gone longer (depending on UV exposure, humidity etc). Get your Kratom Keychain Today!
Its a long read but interesting...
KRATOM AND OTHER MITRAGYNINES
Complete pdf : click on the photo of the book image at the top link below, then scroll down to select the pdf download. It's about 2.49 MB in size. Enjoy.
download: https://www.reddit.com/r/krato.
Edited to fix the link (?)..